Artelo Biosciences Director Reyes Gregory Receives 136-Share Award

What Happened Reyes Gregory, a director of Artelo Biosciences, was granted 136 derivative shares (award) on July 17, 2026. The shares were issued at $0.00 (no cash paid), so the reported acquisition value is $0. This is an equity award subject to vesting, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-17; Form 4 filed: 2026-07-21 (filed within the SEC’s reporting window).
• Transaction type/code: Award/Acquisition (A).
• Shares granted: 136 shares; price reported: $0.00; reported total value: $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: Vesting Commencement Date = July 17, 2026. 100% of the shares vest on the earlier of (i) the one-year anniversary of the Vesting Commencement Date or (ii) the day prior to the date of the issuer’s next annual stockholder meeting, provided the reporting person remains a “Service Provider” through each applicable vesting date.

Context This was a standard equity award to a director and does not indicate an immediate sale or exercise. Because the shares are derivative and subject to service-based vesting, they are not yet freely tradable until the vesting condition is met. Awards like this are common director compensation and should be interpreted as routine unless accompanied by other trading activity.